92 related articles for article (PubMed ID: 9265802)
1. An unexpected complication of DVT prophylaxis.
Manktelow AR; Haddad FS; Powles DP
Acta Orthop Belg; 1997 Jun; 63(2):134-5. PubMed ID: 9265802
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of massive subcutaneous chest wall haemorrhage with enoxaparin.
Rahman MS; Soo L; Qasim A
Acute Card Care; 2011 Sep; 13(3):199-201. PubMed ID: 21877880
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin as prophylaxis against thromboembolism after total hip replacement.
Pedell L
N Engl J Med; 1997 Feb; 336(8):585; author reply 586. PubMed ID: 9036311
[No Abstract] [Full Text] [Related]
5. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
6. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
7. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
Marlovits S; Striessnig G; Schuster R; Stocker R; Luxl M; Trattnig S; Vécsei V
Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
[TBL] [Abstract][Full Text] [Related]
8. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors.
Dickinson LD; Miller LD; Patel CP; Gupta SK
Neurosurgery; 1998 Nov; 43(5):1074-81. PubMed ID: 9802851
[TBL] [Abstract][Full Text] [Related]
10. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
Garcia-Zozaya I
J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin in elective percutaneous coronary intervention.
Karthikeyan G
N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195310
[No Abstract] [Full Text] [Related]
13. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
Lassen MR; Borris LC
Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
[TBL] [Abstract][Full Text] [Related]
14. Peripheral nerve block catheters and low molecular weight heparin.
Ben-David B; Chelly JE
Anesth Analg; 2007 Apr; 104(4):990-1; author reply 991-2. PubMed ID: 17377121
[No Abstract] [Full Text] [Related]
15. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
[TBL] [Abstract][Full Text] [Related]
16. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
17. [Serious complication after subcutaneous injection of heparin for prophylaxis of thromboembolism. Case report].
Andereya S; Kälicke T; Hopf KF; Buschmeier M; Muhr G
Unfallchirurg; 2003 Feb; 106(2):182-3. PubMed ID: 12624693
[TBL] [Abstract][Full Text] [Related]
18. Bleeding complications from femoral and sciatic nerve catheters in patients receiving low molecular weight heparin.
Bickler P; Brandes J; Lee M; Bozic K; Chesbro B; Claassen J
Anesth Analg; 2006 Oct; 103(4):1036-7. PubMed ID: 17000826
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin-associated fat necrosis of the breast.
Das AK
Age Ageing; 2005 Mar; 34(2):193-4. PubMed ID: 15713870
[TBL] [Abstract][Full Text] [Related]
20. Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function.
Quiles J; Avanzas P; Bueno H
Int J Cardiol; 2005 Feb; 98(3):523-4. PubMed ID: 15708194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
